Dr. Ramfis Nieto-Martinez is a Venezuelan MD, researcher, and professor specializing in Internal Medicine, with an MSc in Nutrition. He is the CEO of Precision Care Corp (PCC), FL, USA, and a Lown Scholar at the Cardiovascular Health Program of the TH Chan School of Public Health, Harvard University. Previously, he directed the Cardiometabolic Health and Lifestyle Unit at Lifedoc Health, Memphis, TN, USA (2020-2022) and coordinated the Glycemia Reduction Approaches in Diabetes Study (GRADE) in the Miami VA Medical Center (2017-2020). He is the principal investigator of the Venezuelan Cardiometabolic Health Study (EVESCAM) and currently serves as President (2022-2026) of the Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN). His research focuses on transcultural endocrinology, particularly cardiovascular and diabetes prevention in Venezuela and Latin America. His goals include defining cardiometabolic risk factors, identifying cut-offs for anthropometric and risk scores, and metabolic phenotypes, and transculturalizing and implementing diabetes and cardiovascular prevention and care strategies. He is validating the dysglycemia-based chronic disease model (DBCD) in Latin America along with the METRICS consortium and organizing transcultural DBCD consensus conferences in Chile, Mexico, Brazil, and other countries.